The HGH Fragment 176-191 is evolved from the Human Growth Hormone (HGH) computed as the last segments, 177 to 191 of amino acids. It is the lipolytic fragment portion of HGH, “known as AOD-9604 or simply the fat-reducing moiety,” that comprises this synthetic sequence. This fragment has proved its potential as a weight loss facilitator in the animal models of obesity. While it has a positive safety profile established through multiple clinical trials, it is to be noted that Fragment 176-191 remains a research chemical and has not yet been endorsed for therapeutic application.
Reviews
There are no reviews yet.